Literature DB >> 16756260

Linear basal cell carcinoma: A distinct clinical entity.

I Mavrikakis1, R Malhotra, D Selva, S C Huilgol, R Barlow.   

Abstract

The purpose of the study is to describe linear basal cell carcinoma (BCC) as a distinct clinical entity, and highlight its existence to the plastic surgery literature. A Medline and PubMed literature search was conducted, and 33 reported cases of linear BCC were analysed. Of these 33 cases, the most common site for linear BCC was the periocular region, accounting for 49% (n= 16). The most common histologic subtype, was nodular BCC, accounting for 50% (n= 17). Of the 33 reported cases the postoperative defect size was mentioned in five cases only. None of these would have been completely excised if a 2 mm margin was applied, and only one out of five if a 4 mm margin was applied. Linear BCC is a distinct clinical entity. Presence of the tumour along relaxing skin tension lines, increase in subclinical extension, and aggressive tumour behavior are reported observations. Because of these observations it is suggested that margin-controlled excision should be considered for linear BCC.

Entities:  

Mesh:

Year:  2006        PMID: 16756260     DOI: 10.1016/j.bjps.2005.09.039

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  3 in total

1.  Linear Malignant Melanoma In Situ: Reports and Review of Cutaneous Malignancies Presenting as Linear Skin Cancer.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2017-09-18

2.  Linear Basal cell carcinoma in an asian patient.

Authors:  Kinoshita Shinsuke; Kakizaki Hirohiko; Takahashi Yasuhiro; Hara Kazuo; Iwaki Masayoshi
Journal:  Open Ophthalmol J       Date:  2007-12-17

Review 3.  Histology of Non-Melanoma Skin Cancers: An Update.

Authors:  Giovanni Paolino; Michele Donati; Dario Didona; Santo Raffaele Mercuri; Carmen Cantisani
Journal:  Biomedicines       Date:  2017-12-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.